Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buprenorphine Transdermal Patch vs Morphine in Cancer Pain
NCT03967327Phase 3Unknown
- Sponsor
- Mundipharma
- Start
- Apr 2019
- Primary completion
- Dec 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of buprenorphine in cancer pain, sponsored by Mundipharma. Status: unknown.
02
Drugs
buprenorphine
03
Conditions
cancer pain
Beyond the preview
Go deeper on NCT03967327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03967327.